Operating CF
119B DKK
Capex
-87.6B DKK
Free Cash Flow
31B DKK
FCF Margin
+26.2%
Cash flow waterfall for Novo Nordisk (NVO) — TTM through Q1 2026
Free cash flow: 31B DKK
Cash flow breakdown for Novo Nordisk (NVO) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Operating Cash Flow | 119B DKK | 119B DKK |
| Capital Expenditure | -87.6B DKK | 31B DKK |
| Free Cash Flow | 31B DKK | 31B DKK |
| Other Investing | 3.37B DKK | 34.4B DKK |
| Share Buybacks | -2.4B DKK | 32B DKK |
| Dividends Paid | -51.8B DKK | -19.8B DKK |
| Net Debt Change | 24.2B DKK | 4.35B DKK |
| Other Financing & FX | -22.2B DKK | -17.8B DKK |
| Net Cash Decrease | -17.8B DKK | -17.8B DKK |
- Operating Cash Flow119B DKK
- Capital Expenditure-87.6B DKK
- Free Cash Flow31B DKK
- Other Investing3.37B DKK
- Share Buybacks-2.4B DKK
- Dividends Paid-51.8B DKK
- Net Debt Change24.2B DKK
- Other Financing & FX-22.2B DKK
- Net Cash Decrease-17.8B DKK
Want to see what drove the FCF change?Free Cash Flow Bridge
Frequently asked questions
Data & methodology
Novo Nordisk (NVO) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Forecast & Valuation
Operations
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return
- Buybacks0.23% TTM
- Dividend Profile3.74% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History5 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.